Biofil Chemicals & Pharmaceuticals Ltd.
| BSE: 524396 |
Sector: Health care |
| NSE: BIOFILCHEM |
ISIN Code: INE829A01014 |
|
BSE
00:00 | 01 Jul
|
50.10
|
-0.65
(-1.28%)
|
OPEN
50.20
|
HIGH
50.60
|
LOW
48.60
|
|
NSE
00:00 | 01 Jul
|
50.05
|
(%)
|
OPEN
49.60
|
HIGH
50.70
|
LOW
48.30
|
| OPEN |
50.20 |
| PREVIOUS CLOSE |
50.75 |
| VOLUME |
1740 |
| 52-Week high |
107.00 |
| 52-Week low |
39.80 |
| P/E |
116.51 |
| Mkt Cap.(Rs cr) |
82 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
49.60 |
| PREVIOUS CLOSE |
|
| VOLUME |
15624 |
| 52-Week high |
107.00 |
| 52-Week low |
39.60 |
| P/E |
116.51 |
| Mkt Cap.(Rs cr) |
82 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
50.05 |
| Sell Qty |
575.00 |
| OPEN |
50.20 |
| CLOSE |
50.75 |
| VOLUME |
1740 |
| 52-Week high |
107.00 |
| 52-Week low |
39.80 |
| P/E |
116.51 |
| Mkt Cap.(Rs cr) |
82 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
49.60 |
| PREVIOUS CLOSE |
|
| VOLUME |
15624 |
| 52-Week high |
107.00 |
| 52-Week low |
39.60 |
| P/E |
116.51 |
| Mkt Cap.(Rs cr) |
81.51 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
50.05 |
| Sell Qty |
575.00 |
Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) - Company History
|
Biofil Chemicals & Pharmaceuticals (BCPL) was incorporated as a private limited company on 4 Jan.'85 for manufacture of pharmaceutical products and it was converted into a public limited company on 7 May '92. It was promoted by the Systematix group and Ramesh Shah of the Cyano group. Ramesh Shah is the chairman and managing director and Anand Kumar Sethiya is the managing director. In Feb.'96 the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively both aggregating Rs 23.21 cr to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections capsules eye-drops and dry syrups at its plant located in Indore. BCPL's new unit is being set up at Pithampur in Madhya Pradesh at a project cost of Rs 39.75 cr and will manufacture bulk drugs like astemizole cefaclor pentazocine cefazolin sodium and cefotoxime sodium. It is also setting up a R&D centre which will include a pilot plant for bulk drugs and separate sections for formulations development and will house modern analytical instruments.During the year 1999-2000 the company had achieved a turnover of Rs.1164.03 lakhs.
|
Quick Links for Biofil Chemicals & Pharmaceuticals:
